Melatonin and melatonin-agonists for metabolic syndrome components in patients treated with antipsychotics: A systematic review and meta-analysis.
Alessandro MiolaMichele FornaroPaul A TaylorMarco SolmiPublished in: Human psychopharmacology (2021)
Melatonin/ramelteon augmentation may be beneficial for non-anthropometric metabolic syndrome components in patients treated with antipsychotics.